CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.765
EU - Europa 7.497
AS - Asia 7.395
SA - Sud America 987
AF - Africa 150
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 23.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.622
SG - Singapore 3.666
RU - Federazione Russa 3.522
CN - Cina 1.625
GB - Regno Unito 979
BR - Brasile 765
VN - Vietnam 685
HK - Hong Kong 638
IT - Italia 623
FR - Francia 606
IE - Irlanda 541
KR - Corea 293
DE - Germania 292
UA - Ucraina 282
SE - Svezia 249
FI - Finlandia 151
ID - Indonesia 94
IN - India 89
AR - Argentina 84
CA - Canada 71
BD - Bangladesh 55
NL - Olanda 52
EC - Ecuador 49
MX - Messico 45
AT - Austria 37
TR - Turchia 36
JP - Giappone 33
ZA - Sudafrica 33
PL - Polonia 32
ES - Italia 31
CO - Colombia 27
IQ - Iraq 25
AU - Australia 24
TG - Togo 22
CL - Cile 20
BE - Belgio 18
PH - Filippine 18
BJ - Benin 17
PK - Pakistan 17
NG - Nigeria 16
EG - Egitto 13
PE - Perù 13
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
VE - Venezuela 11
DZ - Algeria 9
JO - Giordania 9
LT - Lituania 9
MA - Marocco 9
NP - Nepal 9
RO - Romania 9
AZ - Azerbaigian 8
KE - Kenya 8
KZ - Kazakistan 8
MY - Malesia 8
SA - Arabia Saudita 8
AL - Albania 7
CZ - Repubblica Ceca 7
CH - Svizzera 6
IL - Israele 6
OM - Oman 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
HN - Honduras 5
HU - Ungheria 5
NO - Norvegia 5
UY - Uruguay 5
KW - Kuwait 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
LB - Libano 2
ME - Montenegro 2
Totale 23.796
Salva come PNG Salva come JPEG
Città #
Singapore 1.859
Ashburn 1.273
San Jose 1.033
Moscow 966
Southend 844
Jacksonville 788
Hong Kong 627
Dallas 578
Chandler 548
Dublin 539
The Dalles 455
Verona 374
Beijing 287
Lawrence 262
Princeton 262
Ho Chi Minh City 220
Wilmington 220
Los Angeles 163
Hanoi 137
Jinan 121
Redondo Beach 111
Munich 105
Helsinki 103
Buffalo 97
New York 88
Shenyang 81
Ann Arbor 80
Dong Ket 79
Council Bluffs 77
São Paulo 72
Santa Clara 68
Jakarta 63
Tianjin 60
Sindelfingen 59
Nanjing 52
Ningbo 51
Changsha 50
Milan 42
Orem 42
Haikou 41
Hebei 41
London 41
San Francisco 39
Columbus 38
Hangzhou 38
Seattle 37
Chennai 36
Guangzhou 36
Houston 34
Zhengzhou 34
Taizhou 32
Nuremberg 31
Tokyo 31
Brooklyn 30
Fairfield 30
Nanchang 30
Warsaw 29
Da Nang 28
Amsterdam 26
Frankfurt am Main 26
Taiyuan 25
Norwalk 24
Redwood City 23
Turku 23
Boston 22
Lomé 22
Rio de Janeiro 22
Stockholm 22
Falkenstein 21
Haiphong 21
Lanzhou 21
Montreal 21
Washington 21
Guayaquil 20
Toronto 20
Johannesburg 19
Brussels 18
Chicago 18
Denver 18
Cotonou 17
Mexico City 17
Lappeenranta 16
Vienna 16
Phoenix 15
Redmond 15
Rome 15
Brasília 14
Jiaxing 14
San Diego 14
Atlanta 13
Belo Horizonte 13
Biên Hòa 13
Curitiba 13
Manchester 13
Woodbridge 13
Abuja 12
Fuzhou 12
Romola 12
Ankara 11
Boardman 11
Totale 14.334
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 264
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 198
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 193
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 188
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 178
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 158
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 150
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 145
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 144
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 141
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 140
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 137
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 137
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 136
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 129
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 128
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 126
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 125
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 125
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 125
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 122
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 122
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 121
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 121
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 121
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 120
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 120
Alteration in endothelial function in cirrhosis 118
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 118
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 116
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 115
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 114
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 114
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 113
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 110
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 110
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 110
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 108
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 108
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 107
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 107
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 106
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 106
Alterazioni epatiche in corso di scompenso cardiaco 103
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 102
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 102
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 102
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 100
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 100
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 99
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 99
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 98
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 98
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 97
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 97
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 97
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 96
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 96
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 96
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 95
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 95
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 95
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 95
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 94
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 94
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 94
Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis” 91
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 91
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 91
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 91
Left ventricular diastolic function in liver cirrhosis 91
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 91
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 91
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis 91
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 90
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 90
Renal function in congestive heart failure. 90
Platelets in Non-alcoholic Fatty Liver Disease 90
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 89
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 89
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 88
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 88
Drugs in the prevention of rebleeding in cirrhosis 88
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 88
The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations 88
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 88
intrahepatic arterioportal fistulas in cirrhosis: usefulness of echo-Doppler as screening procedure 88
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 88
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery 88
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 88
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 87
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 87
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 86
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 86
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler 86
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 85
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 85
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 85
Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler 85
Disegreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation 85
Totale 10.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.503
article - articoli 74.451
book - libri 915
conference - conferenze 14.613
curatela - curatele 0
other - altro 503
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.021
Totale 189.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 8 332 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/202611.752 1.149 687 692 1.848 2.728 880 1.327 976 906 559 0 0
Totale 24.258